Can Bevacizumab Be Recommended in High-Risk Melanoma?

Treatment of high-risk melanoma with adjuvant bevacizumab following resection improves disease-free survival over standard observation, but not overall survival.

Source: CancerNetwork - July 24, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news